INTRODUCTION AND OBJECTIVES: Previous studies have developed various predictive models for stone-free rate following extracorporeal shock wave lithotripsy (ESWL). However, these models have several limitations such as difficulty in usage and lack of information derived from CT imaging. In this study, we sought to develop a user-friendly predictive model for ESWL outcome using the classification and regression tree (CART) analysis.
INTRODUCTION AND OBJECTIVES: Previous studies have developed various predictive models for stone-free rate following extracorporeal shock wave lithotripsy (ESWL). However, these models have several limitations such as difficulty in usage and lack of information derived from CT imaging. In this study, we sought to develop a user-friendly predictive model for ESWL outcome using the classification and regression tree (CART) analysis.
METHODS: We retrospectively reviewed charts of 245 patients who underwent ESWL for upper urinary tract calculi between January 2008 and January 2016. To create the CART decision tree, predictor variables were entered into the software (R version 3.2.2) to classify patients who achieved stone-free after a first session of ESWL. Variables included age, sex, hydronephrosis, urinary drainage, stone location, stone volume, number of stones and three indices based on CT attenuation of the stone, i.e., mean stone density (MSD), standard deviation of stone density (SDSD) and variation coefficient of stone density (VCSD). Stone-free status was determined as absence or residual fragments <4mm using NCCT within three months after a first session of ESWL.
RESULTS: Overall stone-free rate was 47.8%. In CART analysis, VCSD had the greatest variable importance (100%) followed by MSD (56.7%), stone volume (52.7%) and SDSD (49.3%). A total of five subgroups of patients with distinct stone-free rate were produced by three predictive variables ( Figure) .
CONCLUSIONS:
We have generated a first CART decision tree for ESWL outcome that included VCSD as a novel and most important factor, as well as previously reported predictors such as MSD and stone volume. This model provides clinician with practical bedside tool for predicting stone-free following ESWL. METHODS: Among 335 ESWL treatments performed at Nagoya City University Hospital from December 2011 to August 2016, we analyzed the 324 cases that could be evaluated by CT three months post-ESWL treatment. All 17 urologists in charge of treatment attended the technical training. We analyzed associations between success rate and the following parameters: patient factors (age and body mass index), kidney stone factors (size, CT value, constituents, intervening period and skin-to-stone distance), conformity to the recommended techniques from training, number of ESWL sessions, grade of hydronephrosis, indwelling of ureteral stents, therapeutic position, use of stretcher wedges, targeting methods, air removal between cushion and skin, type of ESWL apparatus (Gemini or Lithotripter S, Dornier MedTech, Japan), shock wave frequency, and period from apparatus adjustment (stone model tests). The techniques recommended in training were 1) combined use of fluoroscopy and ultrasonography for targeting renal and proximal ureter stones, 2) use of stretcher wedges for middle ureter stones, and 3) semi-supine position with stretcher wedges for distal ureter stones.
Source of
RESULTS: The average total success rate was 84.3% over the study period. Average conformity to the training techniques was 80.2%, and the average success rates of the conformity and nonconformity groups were 86.2% and 76.6%, respectively (p<0.0001). There was a significant difference in the success rates between the types of apparatuses used, where the Gemini group success rate was 90.1% and the Lithotripter S group success rate was 82.0% (p<0.0001). The number of the selected cases with conformity of the recommended techniques, air removal, low CT values (1000HU), appropriate stone size (10mm), and the first therapy were 90 and their success rate was 95.6%.
CONCLUSIONS: Conforming to recommended techniques, air removal, and appropriate case selection can all lead to higher success rates in ESWL. This study aims to review whether bowel preparation or fasting for six hours prior to SWL will improve stone visualisation on the day of treatment, reduce cancellations and improve calculi clearance rates.
METHODS: This is a single centre, randomised controlled trial, with ethics approval granted from Monash Health Human Research and Ethics Committee (approval number: 16324A). Patients who were selected for SWL were then consented for participation in the trial. Patients were randomly allocated to one of the three arms of the trial; 1. Two sachets of Sodium Picosulphate, 2. Six hours of fasting or 3. Fasting for two hours. Sodium Picosulphate sachets were provided by Fresenius-Kabi. Patients were included into the study if they had intrarenal calculi measuring between 8-12mm. Patients were excluded from the study, if they were over 75 years of age, had more than three medical co-morbidities or had any cardiac/renal conditions. At six weeks post SWL, all patients had a CT KUB to assess stone clearance and completed a survey on their subjective experience of the trial. Statistical analysis was performed using SPSS, t-test.
RESULTS: Sixty patients were recruited in total, twenty into each of the three arms. In the bowel preparation group, there were no cancellations on the day of SWL treatment. All stones were fragmented, with one patient needing a repeat treatment for a 5mm intra-renal fragment. Of the patients who were fasting for either the six hours or the two hours, each group had two cancellations on the day of the procedure for poor visualisation of the calculus. This was a statistically significant difference of p ¼ 0.03 between the bowel preparation and fasting groups. There were no complications related to the bowel preparation or fasting. There was no loss to follow-up. Patient satisfaction was high across all three groups, including those who received bowel preparation.
CONCLUSIONS: Giving bowel preparation within twelve hours of SWL appears to be an effective method of reducing bowel gas interference and improving the calculi visualisation at the time of SWL, resulting in fewer cancellations. Fasting for extended periods of time does not seem to make a significant difference. We are in the process of recruiting more patients to the study. 
Source of Funding: None

INTRODUCTION AND OBJECTIVES:
In our first-in-human trial with ultrasonic propulsion (UP), we moved stones in 14 of 15 subjects and 4 post-lithotripsy subjects passed an aggregate of over 30 stone fragments. Our experience suggested probe heating would limit the duration of the push pulse and the rate at which treatment could be delivered with the clinical C5-2 probe. We have developed a new UP probe (SC-50) that provides a more uniform beam design with greater focal extent in depth and reduced probe heating.
METHODS: The calyx phantom consisted of a pipette (12 mm x 30 mm) embedded in a block of tissue mimicking material at two skin-tostone depths (4.2 cm and 9.5 cm). Three separate targets were placed into the pipette: a single 7 mm x 4 mm calcium oxalate stone, ten 1-2 mm calcium oxalate fragments, and ten 2-3 mm calcium oxalate fragments. The original C5-2 probe or the new SC-50 probe was positioned below the phantom pushing against gravity. Ten pushes at maximum focal intensity were applied, The C5-2 probe was tested with a push duration of 50 ms, the maximum used in human clinical trial, while the SC-50 probe was tested with push durations of 50 ms and 3000 ms. The capability of the two probes to expel the stone or fragments with each push was summed over the ten push attempts. RESULTS: Stone expulsion was similar for the C5-2 and the new SC-50 probe with a push duration of 50 ms. No stones or fragments were expelled the full 30 mm distance with the C5-2 probe and only 2-3% of the stone fragments were expelled with the SC-50 probe. Extending the total Push duration to 3000 ms, available only with the SC-50 probe, results in 100% of stones and all fragments expelled independent of depth from 4.5 cm to 9.5 cm and with less temperature rise within the probe.
CONCLUSIONS: We have developed a new custom designed probe for ultrasonic propulsion that allows for longer duration pushes and reduced probe heating than the commercial probe used in our firstin-human clinical trial, and thus allows for longer duration pushes, than the first-in-human clinical system. The new probe provides similar focal intensity up to 10 cm depth and is significantly more efficient at clearing single stones and stone fragments of various sizes at a range of skin to stone distances. The longer duration push has been shown safe in preclinical studies . Future work is currently in progess for FDA approval of the new probe.
Source of Funding: Work support by NIH NIDDK grants DK043881 and the National Space Biomedical Research Institute through NASA NCC 9-58.
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